GTF3A Activators can be broadly categorized into two groups. The first group includes Sodium butyrate, Trichostatin A, 5-Azacytidine, Decitabine, Nicotinamide, Anacardic Acid, Vorinostat, and Romidepsin. These compounds are either inhibitors of histone deacetylases (HDACs) or DNA methyltransferases. HDACs and DNA methyltransferases both contribute to a closed chromatin structure, which can inhibit the binding of transcription factors like GTF3A to DNA. By inhibiting these enzymes, the compounds in this group can facilitate an open chromatin structure, enhancing GTF3A's ability to bind to DNA and initiate transcription. The second group of GTF3A activators includes TFIIE, TBP-associated factors (TAFs), and TFIIF. These are all components of the transcription initiation complex, with which GTF3A interacts to initiate transcription. The presence of these molecules can enhance GTF3A's functional activity by recruiting it to the transcription initiation complex. In this way, GTF3A's role in transcription initiation, a process fundamental to gene expression, is enhanced by thepresence of these compounds. Overall, all these compounds work in synergy to increase the functional activity of GTF3A, either by facilitating its binding to DNA or by promoting its recruitment to the transcription initiation complex.
Importantly, these GTF3A activators can directly or indirectly enhance the functional activity of GTF3A through specific biochemical or cellular pathways that GTF3A is directly involved in. For example, HDAC inhibitors like Sodium butyrate, Trichostatin A, Nicotinamide, Vorinostat, and Romidepsin can lead to an open chromatin structure, enhancing GTF3A's ability to bind to DNA, a critical part of the transcription initiation process. Similarly, DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine can prevent the formation of a closed chromatin structure, promoting GTF3A's binding to DNA. On the other hand, the presence of molecules like TBP, TFIIE, TAFs, and TFIIF, which are part of the transcription initiation complex, can enhance GTF3A's functional activity by recruiting it to this complex.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a histone deacetylase (HDAC) inhibitor. By inhibiting HDAC, it can lead to an open chromatin structure and enhance the binding of GTF3A to DNA, which is a critical part of the transcription initiation process that GTF3A is involved in. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is another HDAC inhibitor. By blocking HDAC, it induces an open chromatin structure, thus aiding GTF3A's ability to bind to DNA and participate in transcription initiation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. DNA methylation can lead to a closed chromatin structure, blocking transcription factor binding. Therefore, by inhibiting DNA methylation, 5-Azacytidine can promote GTF3A's ability to bind to DNA and initiate transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine is another DNA methyltransferase inhibitor. By inhibiting this enzyme, Decitabine can prevent DNA methylation and promote GTF3A's ability to bind DNA and initiate transcription. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Nicotinamide is an inhibitor of the SIRT1 protein, which is a type of HDAC. By inhibiting SIRT1, Nicotinamide can enhance GTF3A's ability to bind to DNA and initiate transcription. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic Acid is an inhibitor of p300, a histone acetyltransferase. By inhibiting p300, Anacardic Acid can prevent the acetylation of histones, which can enhance GTF3A's ability to bind to DNA and initiate transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a HDAC inhibitor. By inhibiting HDAC, Vorinostat can lead to an open chromatin structure, enhancing GTF3A's ability to bind to DNA and initiate transcription. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin is a potent HDAC inhibitor. By inhibiting HDAC, Romidepsin can enhance GTF3A's ability to bind to DNA and initiate transcription. | ||||||